Abingdon, UK - AMSBIO has published a new 25-page Neuroscience catalogue that details its extensive range of specific tools and reagents to enable researchers stay at the forefront of their field.
Cellular models are key tools that open the door to numerous neuroscience applications including neurodegeneration, neurogensis and developmental diseases. With the discovery that neural stem cells exist in the adult brain many researchers are now seeking to use these cells in in vitro studies. To restore normal function in numerous disorders, including Parkinson's Disease and Alzheimers Disease, neural stem cell transplantation is an important emerging strategy. Furthermore, the recent advent of iPSC and genome editing technology including CRISPR has transformed the scope of neuroscience research allowing the generation of isogenic models and the ability to obtain large numbers of neural stem cells, which had been traditionally difficult to obtain. As many researchers acknowledge the importance of studying the behaviour of neurons, glial cells and neural stem cells with a physiologically relevant context the importance of 3D cell culture has grown.
Beautifully illustrated the new catalogue provides detailed information on the latest neural stem cells, cell culture media / supplements, matrices, scaffolds, cryopreservation media and neural transfection products available from AMSBIO.
AMSBIO is a leading transatlantic based source for neural cells, media and supplements including iPSC-derived cells. The company's large range of substrates and matrices including natural extracellular matrices and artificial scaffolds give you numerous options to develop your in vitro system. AMSBIO also offer proteins, specialised antibodies, ELISA kits, cryopreservation media and an extensive biorepository with neural tissue from numerous species. AMSBIO has an active program of cooperation with leading labs around the world enabling it to continually add new resources to its cutting edge neuroscience range.
For a copy of the new catalogue or further information on the cutting edge neuroscience range please visit www.amsbio.com/neuroscience.aspx or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / email email@example.com.
About AMSBIO Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as an expert in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance organoid and spheroid type screening outcomes from a technological and cost-effective perspective.
Worldwide HQ AMS Biotechnology (AMSBIO) 184 Milton Park Abingdon Oxon OX14 4SE UK Tel: +44-1235-828200 Fax: +44-1235-820482 Email: firstname.lastname@example.org Web www.amsbio.com
North American HQ AMSBIO LLC 1035 Cambridge Street Cambridge MA 02141 USA Tel: +1 617-945-5033 Tel: +1 800-987-0985 (toll free) Email: email@example.com Web www.amsbio.com
Media Contact Dr Bill Bradbury firstname.lastname@example.org